<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Nur353StrategyBoard by </title>
      <link>https://padlet.com/rebecca1bryant/oy5cvngsrod6</link>
      <description>CRRT Implementation</description>
      <language>en-us</language>
      <pubDate>2016-09-25 18:27:41 UTC</pubDate>
      <lastBuildDate>2016-09-25 20:50:23 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>Purpose Panel: </title>
         <author>rebecca1bryant</author>
         <link>https://padlet.com/rebecca1bryant/oy5cvngsrod6/wish/126227630</link>
         <description><![CDATA[<div>Purpose:<br>The purpose of this is to implement a renal modality that would allow physicians the ability to better control electrolyte, acid base, and fluid management with hemodynamic uses.<br><br>Ambition-<br>To implement a CRRT program in ICU.<br><br><br></div>]]></description>
         <enclosure url="http://www.ncbi.nlm.nih.gov/pubmed/24731742" />
         <pubDate>2016-09-25 18:29:57 UTC</pubDate>
         <guid>https://padlet.com/rebecca1bryant/oy5cvngsrod6/wish/126227630</guid>
      </item>
      <item>
         <title>Customer Panel</title>
         <author>rebecca1bryant</author>
         <link>https://padlet.com/rebecca1bryant/oy5cvngsrod6/wish/126228232</link>
         <description><![CDATA[<div>Target Market: Critical Care Departments<br><br>Value proposition: Innovation of technology to treat a range of symptoms related to Acute Kidney Injury to avoid hospital transfer due to acuity level.<br><br></div><ul><li>&nbsp;diuretic resistant pulmonary edema</li><li>hyperkalemia&nbsp;</li><li>metabolic acidosis</li><li>uremic complications</li><li>dialyzable intoxications</li></ul><div><br><br></div>]]></description>
         <enclosure url="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1661614/" />
         <pubDate>2016-09-25 18:38:41 UTC</pubDate>
         <guid>https://padlet.com/rebecca1bryant/oy5cvngsrod6/wish/126228232</guid>
      </item>
      <item>
         <title>Operations Panel</title>
         <author>rebecca1bryant</author>
         <link>https://padlet.com/rebecca1bryant/oy5cvngsrod6/wish/126228249</link>
         <description><![CDATA[<div>Partners:</div><ul><li>&nbsp;Nephrologists</li><li>&nbsp;Intensivist</li><li>&nbsp;Pharmacy</li><li>&nbsp;ICU Nursing dept</li><li>&nbsp;Medical Device Manufacture</li><li>Hospital IT</li><li>&nbsp;Education Department</li><li>C-Suite</li><li>Hospital Supply Dept</li><li>Lab</li><li>Vascular Access</li><li>Policy and Procedure Committee </li></ul><div><br><br>Core Competencies:</div><ul><li>Establish criteria for nephrology consult</li><li>Choose a device to deliver CRRT</li><li>Establish and approve a standard order set</li><li>Partner with pharmacy on standard fluids and delivery process and anticoagulation protocol</li><li>Partner with Manufacture to determine training process of device and develop equipment compentencies</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2016-09-25 18:38:53 UTC</pubDate>
         <guid>https://padlet.com/rebecca1bryant/oy5cvngsrod6/wish/126228249</guid>
      </item>
      <item>
         <title>Resource Panel</title>
         <author>rebecca1bryant</author>
         <link>https://padlet.com/rebecca1bryant/oy5cvngsrod6/wish/126228268</link>
         <description><![CDATA[<div>Infrastructure:</div><ul><li> Which CRRT manufacture will you choose?</li><li>Will the manufacture assist with order set development and policy and procedure?</li></ul><div>IT Systems and Data</div><ul><li>What EMR systems are the devices certified for? </li><li>Does the device have safety alarms and do the meet TJC standards.</li><li>How can we track LOS and the criteria to initiate</li></ul><div><br><br><br></div><div><br></div><div><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2016-09-25 18:39:03 UTC</pubDate>
         <guid>https://padlet.com/rebecca1bryant/oy5cvngsrod6/wish/126228268</guid>
      </item>
      <item>
         <title>Financial Panel</title>
         <author>rebecca1bryant</author>
         <link>https://padlet.com/rebecca1bryant/oy5cvngsrod6/wish/126228281</link>
         <description><![CDATA[<ul><li>What is the capitol expense?</li><li>What is the training expense?</li><li>Who will perform the education?&nbsp; How long are the classes?</li><li>Is there additional expenses related to the therapy?&nbsp;</li><li>What is the impact on staffing ratios?</li><li>What is the decrease in LOS to the ICU patient?</li><li>Why do we need this modality?</li><li>Which physician group is in charge of the modality?</li><li>Can we bill for this service?</li></ul><div><br></div>]]></description>
         <enclosure url="http://www.slideshare.net/ringer21/billing-and-charges-for-crrt" />
         <pubDate>2016-09-25 18:39:14 UTC</pubDate>
         <guid>https://padlet.com/rebecca1bryant/oy5cvngsrod6/wish/126228281</guid>
      </item>
      <item>
         <title>Competition and Risk Panel</title>
         <author>rebecca1bryant</author>
         <link>https://padlet.com/rebecca1bryant/oy5cvngsrod6/wish/126228299</link>
         <description><![CDATA[<ul><li>Do we have enough patients to validate financial investments?</li><li>How many hospitals in the area provide this modality in ICU?</li><li>What is the annual transfer rate due to not offering this current therapy?</li><li>What is the potential number of patients that would benefit from this modality?</li><li>Can the device slave into EMR to continue computer charting?</li><li>Can the solutions be scanned to avoid medication errors?</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2016-09-25 18:39:27 UTC</pubDate>
         <guid>https://padlet.com/rebecca1bryant/oy5cvngsrod6/wish/126228299</guid>
      </item>
   </channel>
</rss>
